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It is well known that alexithymic individuals may show significantly higher levels of anxiety, 
depression, and psychological suffering than non-alexithymics. There is an increasing 
evidence that alexithymia may be considered a risk factor for suicide, even simply 
increasing the risk of development of depressive symptoms or per se. Therefore, the 
purpose of this narrative mini-review was to elucidate a possible relationship between 
alexithymia and suicide risk. The majority of reviewed studies pointed out a relationship 
between alexithymia and an increased suicide risk. In several studies, this relationship 
was mediated by depressive symptoms. In conclusion, the importance of alexithymia 
screening in everyday clinical practice and the evaluation of clinical correlates of alexithy-
mic traits should be integral parts of all disease management programs and, especially, of 
suicide prevention plans and interventions. However, limitations of studies are discussed 
and must be considered.
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inTRODUCTiOn
It has been demonstrated in several studies that often alexithymic individuals may show significantly 
higher levels of psychological distress than non-alexithymics and may develop “functional” somatic 
symptoms and psychiatric symptoms such as anxiety and depression (1–3).
Moreover, it has been suggested that alexithymic subjects may scarcely respond to both pharmaco-
therapy and psychotherapy. The characteristic attributes of alexithymic behavior are predominantly 
manifest in social interactions with high emotional significance (4). The affect-avoiding interper-
sonal pattern behavior showed by such subjects is often maladaptive and may elicit disorders and 
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conflicts in important relationships, lastly contributing the risk of 
development of psychiatric symptoms such as depression or anxi-
ety, thus increasing the risk of suicide (5). Moreover, it has been 
demonstrated that alexithymia should be considered as a relative 
stable personality trait (6, 7), enhancing vulnerability to depres-
sive symptoms (8, 9), and is generally associated with higher risk 
of death for several causes (accidents, injury, or violence) (10).
There is an increasing evidence that alexithymia may be 
considered a risk factor for suicide, even simply increasing the 
risk of development of depressive symptoms or per se (11). This 
evidence comes out from the results of several studies conducted 
on both general population and clinical samples of patients with 
psychiatric disorders or medical conditions.
Therefore, the aim of this narrative review was to elucidate 
the possible relationships between alexithymia and suicide risk, 
evaluating published studies on general population, suicide 
attempters, and subjects with psychiatric disorders [such as 
anxiety disorders, affective disorders, eating disorders (EDs), 
etc.]. Studies were identified searching the electronic databases 
such as MEDLINE, Embase, PsycINFO, and the Cochrane 
Library.
STUDieS On ReLATiOnSHiPS  
BeTween ALeXiTHYMiA AnD SUiCiDe 
RiSK in GeneRAL POPULATiOn
So far, two main and relevant studies on general population (both 
conducted in Finland) have been done to evaluate the relation-
ships between alexithymia and suicide risk.
First, a sample of 1,722 participants (735 men and 987 women) 
were evaluated (12). In particular, the study focused on the 
hopelessness, a widely recognized risk factor for suicide (13). 
Researchers found that a lower financial status, poor personal 
health, and reduced working ability independently associated 
with hopelessness. Interestingly, the probability of moderate or 
severe hopelessness was considerably increased in individuals 
with alexithymia and suicidal ideation. They concluded that life 
discontent, depressive symptoms, alexithymia, and suicidal idea-
tion were the most powerful factors associated with moderate to 
severe hopelessness, but causal association was not possible to 
argue as this was a cross-sectional study.
The second study analyzed a huge sample of 1,563 subjects 
in the Kuopio Depression Study (14). Interestingly, this study 
proved that the most common self-report measure of alexithymia 
[the 20-item Toronto Alexithymia Scale (TAS-20)] showed a large 
overlap with a largely used self-report inventory for measuring 
the severity of depression, the Beck Depression Inventory. The 
associations of alexithymia with levels of suicidal ideation across 
time “…were no longer independent when adjusted for con-
comitant changes in the level of depressive symptoms…” (14), 
as reported by author themselves. Thus, the conclusion was that 
depressive symptoms were the mediators between alexithymia 
and psychiatric morbidity, hence including suicide ideation.
All considered, studies on general population support the 
hypothesis of a relationship between alexithymia and suicidal 
ideation mediated by depressive symptoms.
STUDieS On ReLATiOnSHiPS  
BeTween ALeXiTHYMiA AnD SUiCiDe 
RiSK in CLiniCAL SAMPLeS
Several studies on clinical samples of patients with psychiatric 
disorders have confirmed the hypothesis that alexithymia may 
increase the suicide risk, especially through the development of 
depressive symptoms.
Studies on Suicide Attempters
The studies on possible risk factors in suicide attempters are very 
interesting due to several reasons. In fact, subjects who had a 
previous suicide attempt are at risk to reattempt suicide (15, 16). 
Therefore, the evaluation of alexithymia in such subject may be of 
particular interest to include it as a putative risk factor.
Interestingly, three studies have been conducted in suicide 
attempters. First (17), 50 suicide attempters were evaluated within 
24 h after hospital admission, and most of the attempters showed 
depressive symptoms with near half regarded as positive for alex-
ithymia. However, alexithymia was not more prevalent in suicide 
attempters than in non-suicidal subjects with depressive symptoms. 
Depressive symptoms and alexithymia were considerably associ-
ated, but the authors found no significant correlation between alex-
ithymic traits and lethality of the suicide attempt or suicidal intent 
(17). The authors concluded that alexithymia in suicide attempters 
was associated with depressive symptoms, but not intrinsically 
with suicidal behavior. Moreover, in a study conducted on 100 
suicide attempters compared to 60 healthy controls, the sample of 
suicide attempters did not show significantly higher scores on the 
alexithymia rating scale than healthy subjects, and alexithymia was 
not found to be a predominant trait of personality among suicide 
attempters or a significant predictive factor of suicidal behavior (18).
More recently, in a Greek study (19), researchers evaluated 
the possible relationship between alexithymia (measured using 
the Shalling-Sifneos Personality Scale Revised), depression, and 
serum lipids in 50 non-violent suicide attempters and found a 
significant association between alexithymia and depression in 
those who attempted suicide, but only alexithymia was correlated 
with higher serum triglyceride levels.
Overall, no direct link was found between alexithymia and sui-
cidality among suicide attempters, while there was a confirmation 
that measures of alexithymia were strongly related to measures of 
depression.
Studies on Patients with  
Psychiatric Disorders
The prevalence of alexithymia is quite high in subjects with 
psychiatric disorders (20). Therefore, the studies on relation-
ships between alexithymia and suicide risk on clinical samples 
of patients with psychiatric disorders are very interesting as 
alexithymia may predispose to their development or worsen an 
existing one (8, 9, 21, 22).
Studies on Patients with Anxiety Disorders (ADs)
The presence of alexithymic traits in patients with ADs may be 
a risk factor of suicide, simply worsening the AD itself per  se 
3De Berardis et al. Alexithymia and Suicide in Psychiatric Disorders
Frontiers in Psychiatry | www.frontiersin.org August 2017 | Volume 8 | Article 148
or leading to the development of depressive symptoms or even 
a comorbid clinically relevant major depressive episode (MDE) 
(23–25).
Concerning obsessive–compulsive disorder (OCD), it has 
been found that alexithymia and depressive symptoms were 
significantly correlated in subjects with OCD (11). In a study 
on 86 patients with OCD, alexithymia was associated with 
higher suicide risk, especially in patient with poor or absent 
insight and with a greater disorder severity (26). In this study, 
the “Difficulty in Identifying Feelings” (DIF) dimension of 
TAS-20 was positively correlated with higher scores on the 
Scale for Suicide Ideation (SSI). The relationships between 
alexithymia and higher suicide risk were also confirmed 
in another study that pointed out that alexithymic patients 
showed higher suicidal ideation than non-alexithymic 
patients, and this was associated with lower high-density 
lipoprotein (HDL) cholesterol levels and with the DIF sub-
scale of TAS-20, regardless of depressive symptoms (27). 
More recently, De Berardis et  al. (28) further demonstrated 
that alexithymic OCD subjects showed higher disorder sever-
ity, poor or absent insight, and exaggerated responsibility, 
all associated with suicide ideation, regardless of depressive 
symptoms. Again, in this research, the DIF subscale of TAS-20 
was associated with higher SSI scores. Moreover, alexithymia 
and perfectionism have been found to contribute to higher 
suicidality in 81 patients with OCD (29). It should be noted 
that in most studies on patients with OCD, the links between 
alexithymia and depression were evaluated by comparing a 
self-rating scale (TAS-20) with an observer-rated scale, the 
Montgomery Åsberg Depression Rating Scale (MADRS). This 
must be accounted as a potential source of bias. In fact, when 
used as a modified self-report questionnaire, it was found that 
the MADRS focused on core symptoms of depression and was 
less influenced by maladaptive personality traits, and, there-
fore, this bias may be more marked with the observer-rated 
version of the scale (30).
Also in subjects with panic disorder (PD), a significant rela-
tionship between alexithymia and increased suicidal ideation has 
been found linked by a serum lipid dysregulation (31). In par-
ticular, the presence of lower HDL and higher very low-density 
lipoprotein cholesterol levels and DIF subscale of TAS-20 were 
associated with higher suicide ideation in a sample of 72 outpa-
tients with PD. This positive correlation between alexithymia and 
increased suicidal ideation was substantially confirmed also in 
patients with generalized anxiety disorder (32).
Only one study directly evaluated alexithymia and suicide risk 
in posttraumatic stress disorder (PTSD), even if a link between 
alexithymia and posttraumatic symptoms has been showed in 
several studies (20, 33–37). Kusevic et  al. (38) evaluated 127 
veterans from the 1991 to 1995 war in Croatia, and results of the 
study suggested that alexithymia can be considered as a risk factor 
for attempted suicide among war veterans with PTSD. However, 
in this study, no independent measure of depression was used, 
and this may have biased results.
Overall, studies on ADs support the notion of a relationship 
between alexithymia and suicide ideation, even if in the absence 
of clinically relevant depressive symptoms.
Studies on Patients with Affective Disorders
Despite the great number of studies that have evaluated the pres-
ence and clinical correlates of alexithymia in affective disorders 
(AD) such as major depression (MD) (39–42), surprisingly, 
relatively few studies have directly investigated its relationships 
with suicide risk. Alexithymia may be a risk factor of suicide in 
adolescent depression especially in the presence of maladaptive 
early schematas (43). Concerning adults, De Berardis et al. (41) 
evaluated 145 drug-naive adult outpatients with a DSM-IV 
diagnosis of MD and found that alexithymic patients showed 
higher scores on SSI, thus indicating a higher suicide risk. In a 
linear regression model, lower HDL levels, DIF, and “Difficulty in 
Describing Feelings” (DDF) dimensions of TAS-20 were associ-
ated with higher suicide risk.
Moreover, Loas et  al. (24) evaluated a mixed sample of 
patients with both mood (2 with bipolar depression and 35 
with unipolar depression) and ADs and pointed out that alex-
ithymia and, particularly, DIF dimension of TAS-20 had strong 
relationships with suicidal ideations and low cholesterol levels, 
low HDL levels, or low triglycerides levels in patients with both 
mood or ADs.
Recently, Serafini et al. (44) recruited 281 euthymic partici-
pants of whom 62.3% had MD and 37.7% had bipolar disorder 
and showed that such subjects may suffer from significant 
difficulties in processing sensory input (measure with the 
adolescent/adult sensory profile), which have been significantly 
linked with higher depression, impulsivity, alexithymia, and 
hopelessness. Lower registration of sensory input referring to 
hyposensitivity and sensation avoiding referring to hypersen-
sitivity significantly correlated with higher alexithymia and, in 
particular, with DIF and DDF dimensions of TAS-20, account-
ing for higher impulsivity and hopelessness (that may be risk 
factors of suicide).
Taken together, all studies on patients with AD pointed out 
a relationship between alexithymia and suicide ideation, even if 
there are, to date, too few studies to draw definite conclusions.
Studies on Other Psychiatric Disorders
Positive correlations between alexithymia and increased suicide 
risk have been found in other several psychiatric disorders. 
Somatoform disorder patients with lifetime suicide attempts 
might have greater difficulties in identifying and describing 
emotions and are prone to intensely feel and express anger (45). 
Moreover, in patients with conversion disorder (CD), alexithymia 
is higher in suicide attempters (46).
Several evidences point out that alexithymia may be a risk 
factor of suicide in EDs. For example, Carano et  al. (47) dem-
onstrated that individuals with binge eating disorder (BED) 
and alexithymia showed higher suicide ideation than non-
alexithymics, especially in the presence of subclinical depressive 
symptoms. Alpaslan et al. (48) evaluated 381 female students in 
Turkey and found that disordered eating attitudes (DEAs) were 
a quite common phenomenon in female students and the occur-
rence of alexithymia was related with a higher suicide risk in such 
subjects. However, no studies have been conducted to evaluate 
the association between alexithymia and increased suicide idea-
tion in patients with anorexia nervosa and bulimia.
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Moreover, several studies have pointed out that alexithymia 
may be a risk factor for suicide and self-harm in individuals with 
substance use disorders (SUDs) (49–51).
To date, just one study evaluated relationships between 
alexithymia and suicide risk in subjects with schizophrenia, and 
study results showed that the occurrence of alexithymic traits in 
schizophrenia was associated with more prominent suicide idea-
tion and more serious depressive symptoms, independently by 
the severity of positive and negative symptoms (52).
In conclusion, it seems that alexithymia may be a putative 
risk factor for suicide in patients with CD, BED, DEAs, SUD, 
and schizophrenia, but further prospective studies are needed to 
further confirm this association.
OTHeR LiMiTATiOnS OF RevieweD 
STUDieS
We have discussed some limitations of the reviewed studies above 
in the text. However, some other general limitations should be 
acknowledged.
The principal limitation of most studies on the relationships 
between alexithymia and suicide is that these are often cross- 
sectional and not prospective. Therefore, it may be difficult to inter-
pret the identified associations and draw predictive conclusions.
Moreover, almost all reviewed studies employed the TAS-20, 
a self-report scale, to measure alexithymia. Even if the TAS-20 is a 
very useful tool in everyday “real-world” clinical practice to screen 
whether the subject is positive for alexithymia, it should be noted 
that findings based on self-report tools may be source of bias that in 
some cases may be poorly informative. Task-based studies should 
be preferred, but, to date, no task studies evaluating alexithymia 
were developed. However, future studies should employ the 
Toronto Structured Interview for Alexithymia (TSIA) (53), a reli-
able and valid structured interview for assessing the alexithymia 
construct, that can overcome the limitations of TAS-20 (54, 55).
Finally, the lack of control for adequate and comparable 
measures of depression and alexithymia or adequate statistical 
models of the interaction between depression and alexithymia 
(mixed models rather than ANCOVA) was a limitation of several 
reviewed studies, and this should be recognized.
COnCLUSiOn
Taken together, the almost all studies have pointed out a significant 
relationship between alexithymia and an increased suicide risk.
These findings may be explained in several ways. One is 
in accordance to the theory proposed by Freyberger of acute 
“secondary alexithymia” as a response to stressful conditions 
(56). The “acute secondary alexithymia” (56) can be defined 
as a transient, state-dependent experience that may occur as a 
consequence of subjective distress and can decline when an acute 
episode of illness has resolved (57). As the presence of alexithy-
mia may worsen an existing psychiatric or medical disease, this 
worsening may be related to the development of suicidal ideation 
per  se or through the development of depressive symptoms or 
even a comorbid clinically relevant MDE (4). However, even 
if alexithymia may be a state-dependent phenomenon (i.e., 
alexithymia may worsen during an acute disease episode, as 
described above), it should be considered a relatively stable 
personality trait that may be also present even before the onset of 
a psychiatric disorder or a medical disease (6, 7). Thus, research 
findings may be also in accordance with the “stress-alexithymia 
hypothesis” (58): alexithymia may be a chronic condition [maybe 
with an onset during infancy or early adolescence and often in 
consequence of childhood abuse or neglect (49, 59)] character-
ized by a pronounced inflammatory state with an impaired 
hypothalamic–pituitary–adrenal axis reactivity to even mild 
to moderate life stressors (60). Therefore, it should be deemed 
as a chronic state reaction as a response to stressful conditions 
that may always complicate a psychiatric disorder or a medical 
disease (61).
In conclusion, the importance of alexithymia screening in 
everyday clinical practice and the evaluation of clinical correlates 
of alexithymic traits should be integral parts of all disease man-
agement programs and, especially, of suicide prevention plans 
and interventions. The TAS-20 is a very useful tool in everyday 
“real world” clinical practice to screen subject positive or not for 
alexithymia, even if it is a self-report scale with all limitations of 
such instruments. However, if a subject is positive for alexithymia 
on TAS-20, a careful evaluation should be conducted (also com-
pleting the assessment of alexithymia with the TSIA, if possible) 
concerning the presence of depressive symptoms and suicidal 
ideation.
AUTHOR COnTRiBUTiOnS
We state that (1) all authors have read the paper and approved 
the data and the conclusions presented therein; (2) each author 
believes that the paper represents honest work; and (3) all authors 
have contributed to the present paper with equal effort.
ReFeRenCeS
1. Porcelli P, Zaka S, Leoci C, Centonze S, Taylor GJ. Alexithymia in inflam-
matory bowel disease. A case-control study. Psychother Psychosom (1995) 
64:49–53. doi:10.1159/000288990 
2. Bankier B, Aigner M, Bach M. Alexithymia in DSM-IV disorder: comparative 
evaluation of somatoform disorder, panic disorder, obsessive-compulsive 
disorder, and depression. Psychosomatics (2001) 42:235–40. doi:10.1176/appi.
psy.42.3.235 
3. Carano A, De Berardis D, Gambi F, Di Paolo C, Campanella D, Pelusi L, et al. 
Alexithymia and body image in adult outpatients with binge eating disorder. 
Int J Eat Disord (2006) 39:332–40. doi:10.1002/eat.20238 
4. Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother 
Psychosom (2004) 73:68–77. doi:10.1159/000075537 
5. Lester D. Alexithymia, depression, and suicidal preoccupation. Percept Mot 
Skills (1991) 72:1058. doi:10.2466/pms.1991.72.3.1058 
6. Luminet O, Bagby RM, Taylor GJ. An evaluation of the absolute and rela-
tive stability of alexithymia in patients with major depression. Psychother 
Psychosom (2001) 70:254–60. doi:10.1159/000056263 
7. Luminet O, Rokbani L, Ogez D, Jadoulle V. An evaluation of the absolute and 
relative stability of alexithymia in women with breast cancer. J Psychosom Res 
(2007) 62:641–8. doi:10.1016/j.jpsychores.2007.01.003 
8. Honkalampi K, Koivumaa-Honkanen H, Lehto SM, Hintikka J, Haatainen K, 
Rissanen T, et al. Is alexithymia a risk factor for major depression, personality 
5De Berardis et al. Alexithymia and Suicide in Psychiatric Disorders
Frontiers in Psychiatry | www.frontiersin.org August 2017 | Volume 8 | Article 148
disorder, or alcohol use disorders? A prospective population-based study. 
J Psychosom Res (2010) 68:269–73. doi:10.1016/j.jpsychores.2009.05.010 
9. Tolmunen T, Heliste M, Lehto SM, Hintikka J, Honkalampi K, Kauhanen J. 
Stability of alexithymia in the general population: an 11-year follow-up. 
Compr Psychiatry (2011) 52:536–41. doi:10.1016/j.comppsych.2010.09.007 
10. Kauhanen J, Kaplan GA, Cohen RD, Julkunen J, Salonen JT. Alexithymia 
and risk of death in middle-aged men. J Psychosom Res (1996) 41:541–9. 
doi:10.1016/S0022-3999(96)00226-7 
11. De Berardis D, Campanella D, Gambi F, Sepede G, Salini G, Carano A, et al. 
Insight and alexithymia in adult outpatients with obsessive-compulsive 
disorder. Eur Arch Psychiatry Clin Neurosci (2005) 255:350–8. doi:10.1007/
s00406-005-0573-y 
12. Haatainen K, Tanskanen A, Kylma J, Honkalampi K, Koivumaa-Honkanen H, 
Hintikka J, et  al. Factors associated with hopelessness: a population study. 
Int J Soc Psychiatry (2004) 50:142–52. doi:10.1177/0020764004040961 
13. Huen JM, Ip BY, Ho SM, Yip PS. Hope and hopelessness: the role of hope in 
buffering the impact of hopelessness on suicidal ideation. PLoS One (2015) 
10:e0130073. doi:10.1371/journal.pone.0130073 
14. Hintikka J, Honkalampi K, Koivumaa-Honkanen H, Antikainen R, Tanskanen A, 
Haatainen K, et al. Alexithymia and suicidal ideation: a 12-month follow-up 
study in a general population. Compr Psychiatry (2004) 45:340–5. doi:10.1016/j.
comppsych.2004.06.008 
15. Berglund S, Astrom S, Lindgren BM. Patients’ experiences after attempted 
suicide: a literature review. Issues Ment Health Nurs (2016) 37:715–26. 
 doi:10.1080/01612840.2016.1192706 
16. Gorton HC, Webb RT, Kapur N, Ashcroft DM. Non-psychotropic medication 
and risk of suicide or attempted suicide: a systematic review. BMJ Open (2016) 
6:e009074. doi:10.1136/bmjopen-2015-009074 
17. Taiminen TJ, Saarijarvi S, Helenius H, Keskinen A, Korpilahti T. Alexithymia in 
suicide attempters. Acta Psychiatr Scand (1996) 93:195–8. doi:10.1111/j.1600- 
0447.1996.tb10631.x 
18. Sayar K, Acar B, Ak I. Alexithymia and suicidal behavior. Isr J Psychiatry Relat 
Sci (2003) 40:165–73. 
19. Paplos K, Havaki-Kontaxaki B, Ferentinos P, Dasopoulou M, Kontaxakis V. 
Alexithymia, depression and serum lipids in suicide attempters. Psychiatriki 
(2012) 23:149–52. 
20. Leweke F, Leichsenring F, Kruse J, Hermes S. Is alexithymia associ-
ated with specific mental disorders? Psychopathology (2012) 45:22–8. 
doi:10.1159/000325170 
21. Saarijarvi S, Salminen JK, Toikka T. Temporal stability of alexithymia over a 
five-year period in outpatients with major depression. Psychother Psychosom 
(2006) 75:107–12. doi:10.1159/000090895 
22. Conrad R, Wegener I, Imbierowicz K, Liedtke R, Geiser F. Alexithymia, 
temperament and character as predictors of psychopathology in patients 
with major depression. Psychiatry Res (2009) 165:137–44. doi:10.1016/j.
psychres.2007.10.013 
23. De Berardis D, Campanella D, Serroni N, Sepede G, Carano A, Conti C, et al. 
The impact of alexithymia on anxiety disorders: a review of the literature. Curr 
Psychiatry Rev (2008) 4:80–6. doi:10.2174/157340008784529287 
24. Loas G, Dalleau E, Lecointe H, Yon V. Relationships between anhedonia, 
alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive 
protein and serum lipid levels among 122 inpatients with mood or anxious dis-
orders. Psychiatry Res (2016) 246:296–302. doi:10.1016/j.psychres.2016.09.056 
25. De Berardis D, Campanella D, Gambi F, La Rovere R, Sepede G, Core L, et al. 
Alexithymia, fear of bodily sensations, and somatosensory amplification in 
young outpatients with panic disorder. Psychosomatics (2007) 48:239–46. 
doi:10.1176/appi.psy.48.3.239 
26. De Berardis D, Serroni N, Campanella D, Carano A, Caltabiano M, Pizzorno A, 
et al. Suicide risk among patients with obsessive–compulsive disorder: the role 
of alexithymia and insight. G Ital Psicopat (2008) 14:185–96. 
27. De Berardis D, Serroni N, Marini S, Rapini G, Carano A, Valchera A, et al. 
Alexithymia, suicidal ideation, and serum lipid levels among drug-naive 
outpatients with obsessive-compulsive disorder. Rev Bras Psiquiatr (2014) 
36:125–30. doi:10.1590/1516-4446-2013-1189 
28. De Berardis D, Serroni N, Campanella D, Rapini G, Olivieri L, Feliziani B, et al. 
Alexithymia, responsibility attitudes and suicide ideation among outpatients 
with obsessive-compulsive disorder: an exploratory study. Compr Psychiatry 
(2015) 58:82–7. doi:10.1016/j.comppsych.2014.12.016 
29. Kim H, Seo J, Namkoong K, Hwang EH, Sohn SY, Kim SJ, et al. Alexithymia 
and perfectionism traits are associated with suicidal risk in patients with 
obsessive-compulsive disorder. J Affect Disord (2016) 192:50–5. doi:10.1016/j.
jad.2015.12.018 
30. Svanborg P, Asberg M. A comparison between the Beck Depression Inventory 
(BDI) and the self-rating version of the Montgomery Asberg Depression 
Rating Scale (MADRS). J Affect Disord (2001) 64:203–16. doi:10.1016/
S0165-0327(00)00242-1 
31. De Berardis D, Campanella D, Serroni N, Moschetta FS, Di Emidio F, Conti C, 
et al. Alexithymia, suicide risk and serum lipid levels among adult outpatients 
with panic disorder. Compr Psychiatry (2013) 54:517–22. doi:10.1016/j.
comppsych.2012.12.013 
32. De Berardis D, Serroni N, Campanella D, Marini S, Rapini G, Valchera A, 
et al. Alexithymia, suicide ideation, C-reactive protein, and serum lipid levels 
among outpatients with generalized anxiety disorder. Arch Suicide Res (2017) 
21:100–12. doi:10.1080/13811118.2015.1004485 
33. Yehuda R, Steiner A, Kahana B, Binder-Brynes K, Southwick SM, Zemelman S, 
et al. Alexithymia in Holocaust survivors with and without PTSD. J Trauma 
Stress (1997) 10:93–100. doi:10.1002/jts.2490100108 
34. Sondergaard HP, Theorell T. Alexithymia, emotions and PTSD; findings 
from a longitudinal study of refugees. Nord J Psychiatry (2004) 58:185–91. 
doi:10.1080/08039480410006214 
35. Evren C, Dalbudak E, Cetin R, Durkaya M, Evren B. Relationship of alexithy-
mia and temperament and character dimensions with lifetime post-traumatic 
stress disorder in male alcohol-dependent inpatients. Psychiatry Clin Neurosci 
(2010) 64:111–9. doi:10.1111/j.1440-1819.2009.02052.x 
36. Park J, Jun JY, Lee YJ, Kim S, Lee SH, Yoo SY, et al. The association between 
alexithymia and posttraumatic stress symptoms following multiple exposures 
to traumatic events in North Korean refugees. J Psychosom Res (2015) 
78:77–81. doi:10.1016/j.jpsychores.2014.09.007 
37. Terock J, Van der Auwera S, Janowitz D, Spitzer C, Barnow S, Miertsch M, 
et  al. From childhood trauma to adult dissociation: the role of PTSD and 
alexithymia. Psychopathology (2016) 49:374–82. doi:10.1159/000449004 
38. Kusevic Z, Cusa BV, Babic G, Marcinko D. Could alexithymia predict suicide 
attempts – a study of Croatian war veterans with post-traumatic stress disor-
der. Psychiatr Danub (2015) 27:420–3. 
39. Marchesi C, Ossola P, Tonna M, De Panfilis C. The TAS-20 more likely 
measures negative affects rather than alexithymia itself in patients with major 
depression, panic disorder, eating disorders and substance use disorders. 
Compr Psychiatry (2014) 55:972–8. doi:10.1016/j.comppsych.2013.12.008 
40. Li S, Zhang B, Guo Y, Zhang J. The association between alexithymia as assessed 
by the 20-item Toronto Alexithymia Scale and depression: a meta-analysis. 
Psychiatry Res (2015) 227:1–9. doi:10.1016/j.psychres.2015.02.006 
41. De Berardis D, Serroni N, Campanella D, Carano A, Gambi F, Valchera A, 
et  al. Alexithymia and its relationships with C-reactive protein and serum 
lipid levels among drug naive adult outpatients with major depression. Prog 
Neuropsychopharmacol Biol Psychiatry (2008) 32:1982–6. doi:10.1016/j.
pnpbp.2008.09.022 
42. Saarijarvi S, Salminen JK, Toikka TB. Alexithymia and depression: a 1-year 
follow-up study in outpatients with major depression. J Psychosom Res (2001) 
51:729–33. doi:10.1016/S0022-3999(01)00257-4 
43. Hirsch N, Hautekeete M, Kochman F. [Early maladaptive processes, depres-
sion and alexithymia in suicidal hospitalized adolescents]. Encephale (2001) 
27:61–70. 
44. Serafini G, Gonda X, Canepa G, Pompili M, Rihmer Z, Amore M, et al. Extreme 
sensory processing patterns show a complex association with depression, and 
impulsivity, alexithymia, and hopelessness. J Affect Disord (2016) 210:249–57. 
doi:10.1016/j.jad.2016.12.019 
45. Kampfer N, Staufenbiel S, Wegener I, Rambau S, Urbach AS, Mucke M, et al. 
Suicidality in patients with somatoform disorder – the speechless expression of 
anger? Psychiatry Res (2016) 246:485–91. doi:10.1016/j.psychres.2016.10.022 
46. Gulec MY, Ynanc L, Yanartathorn O, Uzer A, Gulec H. Predictors of suicide 
in patients with conversion disorder. Compr Psychiatry (2014) 55:457–62. 
doi:10.1016/j.comppsych.2013.10.009 
47. Carano A, De Berardis D, Campanella D, Serroni N, Ferri F, Di Iorio G, 
et  al. Alexithymia and suicide ideation in a sample of patients with 
binge eating disorder. J Psychiatr Pract (2012) 18:5–11. doi:10.1097/01.
pra.0000410982.08229.99 
6De Berardis et al. Alexithymia and Suicide in Psychiatric Disorders
Frontiers in Psychiatry | www.frontiersin.org August 2017 | Volume 8 | Article 148
48. Alpaslan AH, Soylu N, Avci K, Coskun KS, Kocak U, Tas HU. Disordered 
eating attitudes, alexithymia and suicide probability among Turkish high 
school girls. Psychiatry Res (2015) 226:224–9. doi:10.1016/j.psychres.2014. 
12.052 
49. Evren C, Evren B, Dalbudak E, Ozcelik B, Oncu F. Childhood abuse and 
neglect as a risk factor for alexithymia in adult male substance dependent 
inpatients. J Psychoactive Drugs (2009) 41:85–92. doi:10.1080/02791072.2009. 
10400677 
50. Sakuraba S, Kubo M, Komoda T, Yamana J. Suicidal ideation and alexithymia 
in patients with alcoholism: a pilot study. Subst Use Misuse (2005) 40:823–30. 
doi:10.1081/JA-200030702 
51. Evren C, Evren B. Self-mutilation in substance-dependent patients and rela-
tionship with childhood abuse and neglect, alexithymia and temperament and 
character dimensions of personality. Drug Alcohol Depend (2005) 80:15–22. 
doi:10.1016/j.drugalcdep.2005.03.017 
52. Marasco V, De Berardis D, Serroni N, Campanella D, Acciavatti T, Caltabiano M, 
et  al. [Alexithymia and suicide risk among patients with schizophrenia: 
preliminary findings of a cross-sectional study]. Riv Psichiatr (2011) 
46:31–7. 
53. Bagby RM, Taylor GJ, Parker JD, Dickens SE. The development of the 
Toronto structured interview for alexithymia: item selection, factor structure, 
reliability and concurrent validity. Psychother Psychosom (2006) 75:25–39. 
doi:10.1159/000089224 
54. Keefer KV, Taylor GJ, Parker JD, Inslegers R, Michael Bagby R. Measurement 
equivalence of the Toronto structured interview for alexithymia across 
language, gender, and clinical status. Psychiatry Res (2015) 228:760–4. 
doi:10.1016/j.psychres.2015.04.044 
55. Caretti V, Porcelli P, Solano L, Schimmenti A, Bagby RM, Taylor GJ. Reliability 
and validity of the Toronto structured interview for alexithymia in a mixed 
clinical and nonclinical sample from Italy. Psychiatry Res (2011) 187:432–6. 
doi:10.1016/j.psychres.2011.02.015 
56. Freyberger H. Supportive psychotherapeutic techniques in primary 
and secondary alexithymia. Psychother Psychosom (1977) 28:337–42. 
doi:10.1159/000287080 
57. Kim HW, Rim HD, Kim JH, Lee SJ. Alexithymia and stress response patterns 
among patients with depressive disorders in Korea. Psychiatry Investig (2009) 
6:13–8. doi:10.4306/pi.2009.6.1.13 
58. Martin JB, Pihl RO. The stress-alexithymia hypothesis: theorectical and empir-
ical considerations. Psychother Psychosom (1985) 43:169–76. doi:10.1159/ 
000287876 
59. Swannell S, Martin G, Page A, Hasking P, Hazell P, Taylor A, et  al. Child 
maltreatment, subsequent non-suicidal self-injury and the mediating roles of 
dissociation, alexithymia and self-blame. Child Abuse Negl (2012) 36:572–84. 
doi:10.1016/j.chiabu.2012.05.005 
60. Honkalampi K, Lehto SM, Koivumaa-Honkanen H, Hintikka J, Niskanen L, 
Valkonen-Korhonen M, et al. Alexithymia and tissue inflammation. Psychother 
Psychosom (2011) 80:359–64. doi:10.1159/000327583 
61. De Berardis D, Conti C, Iasevoli F, Valchera A, Fornaro M, Cavuto M, et al. 
Alexithymia and its relationships with acute phase proteins and cytokine 
release: an updated review. J Biol Regul Homeost Agents (2014) 28:795–9. 
Conflict of Interest Statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2017 De Berardis, Fornaro, Orsolini, Valchera, Carano, Vellante, Perna, 
Serafini, Gonda, Pompili, Martinotti and Di Giannantonio. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
